RXSIGHT INC. - COMMON STOCK

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

20 May 2025 13:10:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports First Quarter 2025 Financial Results

07 May 2025 13:05:01 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the Bank of America Healthcare Conference

30 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

23 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

02 Apr 2025 17:00:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

25 Mar 2025 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

25 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

11 Feb 2025 13:10:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

12 Jan 2025 06:30:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

02 Jan 2025 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Third Quarter 2024 Financial Results

07 Nov 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

24 Oct 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

22 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports Second Quarter 2024 Financial Results

05 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

22 Jul 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

05 Jun 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

13 May 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

08 May 2024 18:15:00 By Nasdaq GlobeNewswire

RxSight, Inc. Announces Proposed Public Offering of Common Stock

08 May 2024 13:05:00 By Nasdaq GlobeNewswire

RxSight, Inc. Reports First Quarter 2024 Financial Results

06 May 2024 13:05:00 By Nasdaq GlobeNewswire